Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation
- 1Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China
- 2Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China
- 3Department of Medical Oncology, West China Second University Hospital, Sichuan University, Chengdu, China
Abstract
Ovarian, endometrial, and cervical cancers represent major threats to women’s health worldwide. The profound heterogeneity of their immune microenvironments has rendered immune checkpoint blockade (ICB) therapies, particularly PD-1/PD-L1 inhibitors, far less effective than anticipated in gynecological malignancies. Conventional research approaches, constrained by coarse analytical resolution, are insufficient to unravel the underlying mechanisms of this therapeutic shortfall. Functional single-cell omics technologies, including single-cell RNA sequencing, single-cell chromatin accessibility profiling, spatial transcriptomics, and multi-omics integration, have provided a new framework for systematically studying the tumor immune microenvironment across three progressive dimensions: cellular identity, functional state, and spatial localization. This review systematically synthesizes the applications of this technological toolkit in the three major gynecological cancers. It reveals distinct bottlenecks across the three dimensions. In ovarian cancer, the core obstacle lies in the spatial dimension, where cancer-associated fibroblast-mediated physical barriers and pro-angiogenic macrophage subsets together construct a “spatial exclusion” microenvironment. In cervical cancer, the principal bottleneck resides in the functional dimension, where HPV status and histological subtype drive a “functional disability” phenotype, in which T cells infiltrate but fail to achieve effective activation, with therapy resistance-associated immune evasion clones further exacerbating functional impairment. In endometrial cancer, however, the immune fate is governed by the identity dimension, where molecular subtypes dictate the baseline nature of immune infiltration, and autophagy-related cellular subpopulations may offer new insights into intratumoral heterogeneity. Although single-cell omics has identified immunologically actionable targets with translational potential, including TREM2+ macrophages and the LAG-3/TIM-3 dual-target axis, clinical translation remains constrained by technical and biological bottlenecks, including stringent requirements for tissue sample quality, high assay costs, lack of standardized analytical pipelines, and the discordance between transcriptomic profiles and protein-level functionality.
Related
- Eosinophils in autoimmune diseases: context-dependent pathogenesis, functional heterogeneity, and therapeutic translation
- How to Complete a Gynecological Robot-Assisted Retroperitoneal Lymph Node Dissection with a High-Quality Experience: 180 Cases in a Single Center
- Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non‐Small Cell Lung Cancer: Mechanisms to Clinical Translation
- Clinical Implications of Histologic Heterogeneity in Endoscopic Submucosal Dissection Specimens for Differentiated-Type Early Gastric Cancer.
- Single-cell dissection of shoulder-derived mesenchymal stem cells reveals source-specific progenitor heterogeneity and a SIX2-driven chondrogenic program.
BibTeX
@article{li2026functional,
title = {{Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation}},
author = {Dong-mei Li and Kai-ge Pei and Bo-wen Yang and Ming-rong Qie and Jin-feng Xu and Lan Zhong and Liang Song},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1981010},
url = {https://doi.org/10.3389/fimmu.2026.1981010},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation
AU - Dong-mei Li
AU - Kai-ge Pei
AU - Bo-wen Yang
AU - Ming-rong Qie
AU - Jin-feng Xu
AU - Lan Zhong
AU - Liang Song
PY - 2026
DA - 2026/10/12
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1981010
UR - https://doi.org/10.3389/fimmu.2026.1981010
AB - Ovarian, endometrial, and cervical cancers represent major threats to women’s health worldwide. The profound heterogeneity of their immune microenvironments has rendered immune checkpoint blockade (ICB) therapies, particularly PD-1/PD-L1 inhibitors, far less effective than anticipated in gynecological malignancies. Conventional research approaches, constrained by coarse analytical resolution, are insufficient to unravel the underlying mechanisms of this therapeutic shortfall. Functional single-cell omics technologies, including single-cell RNA sequencing, single-cell chromatin accessibility profiling, spatial transcriptomics, and multi-omics integration, have provided a new framework for systematically studying the tumor immune microenvironment across three progressive dimensions: cellular identity, functional state, and spatial localization. This review systematically synthesizes the applications of this technological toolkit in the three major gynecological cancers. It reveals distinct bottlenecks across the three dimensions. In ovarian cancer, the core obstacle lies in the spatial dimension, where cancer-associated fibroblast-mediated physical barriers and pro-angiogenic macrophage subsets together construct a “spatial exclusion” microenvironment. In cervical cancer, the principal bottleneck resides in the functional dimension, where HPV status and histological subtype drive a “functional disability” phenotype, in which T cells infiltrate but fail to achieve effective activation, with therapy resistance-associated immune evasion clones further exacerbating functional impairment. In endometrial cancer, however, the immune fate is governed by the identity dimension, where molecular subtypes dictate the baseline nature of immune infiltration, and autophagy-related cellular subpopulations may offer new insights into intratumoral heterogeneity. Although single-cell omics has identified immunologically actionable targets with translational potential, including TREM2+ macrophages and the LAG-3/TIM-3 dual-target axis, clinical translation remains constrained by technical and biological bottlenecks, including stringent requirements for tissue sample quality, high assay costs, lack of standardized analytical pipelines, and the discordance between transcriptomic profiles and protein-level functionality.
SN - 1664-3224
ER -